Paid Clinical Trials in Manassas, VA
As of September 2026, 38 paid clinical trials are recruiting in Manassas, Virginia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Manassas offers studies at sites including Carient Heart and Vascular for conditions such as Obesity, Diabetes Mellitus, Type 2, Heart Failure, Cardiovascular Disease. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Manassas
Trials by drug in Manassas
Filter results
Newly added in Manassas
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
37 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Effects of Gait Retraining on Lower Extremity Biomechanics
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Top Research Study Locations in Manassas
Researchers run research studies in Manassas, VA at 16 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Carient Heart and Vascular | Heart Failure, Obesity, Aortic Stenosis | 9 |
| Manassas Clinical Research Center | Type 2 Diabetes Mellitus, Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 4 |
| Carient Heart & Vascular - Manassas | Atherosclerosis, Atherosclerotic Cardiovascular Disease (ASCVD), Cardiovascular Disease | 4 |
| Virginia Cancer Specialists, PC | Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases | 3 |
| GSK Investigational Site | Non-alcoholic Fatty Liver Disease | 2 |
| Kailera Clinical Site | Obesity, Obesity With Diabetes, Overweight With Diabetes | 2 |
| Virginia Cancer Specialists | Acute Myeloid Leukemia (AML), Breast Cancer | 2 |
| ACCOMPLISH-2 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| Carient Heart & Vascular | Atrial Fibrillation (AF) | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Kidney and Hypertension Specialists, PLLC | ASCVD, Type2Diabetes | 1 |
| Kidney and Hypertension Specialists- Virginia | Immunoglobulin A Nephropathy (IgAN) | 1 |
| Manassas Clinical Research Center Inc | Diabetes Mellitus, Type 2, Obesity, Overweight | 1 |
| Prince William Surgery Center | Lumbar Spinal Stenosis | 1 |
| Sports Medicine, Assessment, Research & Testing (SMART) Laboratory | Knee Osteoarthritis | 1 |
| The Spine Care | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Manassas (2026)
Recruiting trials in Manassas grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Diabetes & metabolic (15 active studies)
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event · Phase 2 · Eli Lilly and Company
- A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
Cardiovascular (10 active studies)
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event · Phase 2 · Eli Lilly and Company
- Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation · Phase 3 · Regeneron Pharmaceuticals
Cancer & tumors (4 active studies)
- Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · Phase 2, Phase 3 · Pfizer
- Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML · Phase 3 · Kura Oncology, Inc.
Common conditions studied in Manassas
- Obesity (6 active studies)
- Diabetes Mellitus, Type 2 (4 active studies)
- Heart Failure (4 active studies)
- Cardiovascular Disease (3 active studies)
- Hypertension (3 active studies)
- Obesity or Overweight (3 active studies)
Leading research sponsors in Manassas
- AstraZeneca
- Amgen
- Boehringer Ingelheim
- Eli Lilly and Company
- Novartis Pharmaceuticals
Frequently asked questions
How many paid clinical trials are currently recruiting in Manassas?
There are approximately 38 recruiting clinical trials in Manassas, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Manassas pay participants?
Most recruiting trials in Manassas compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Manassas?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Manassas?
The most common conditions under active study in Manassas include Obesity (6), Diabetes Mellitus, Type 2 (4), Heart Failure (4), Cardiovascular Disease (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Manassas?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Manassas on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Manassas?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Manassas?
Recruiting research sites in Manassas include Carient Heart and Vascular, Manassas Clinical Research Center, Carient Heart & Vascular - Manassas, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Manassas right now?
The largest active categories in Manassas are Diabetes & metabolic (15), Cardiovascular (10), Cancer & tumors (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.